Risk of Thromboembolic Events Following COVID-19 Diagnosis Without Hospitalization

References

1. 1.↵
   1. Vaughn VM,
   2. Yost M,
   3. Abshire C,
   4. et al

   . Trends in venous thromboembolism anticoagulation in patients hospitalized with COVID-19. JAMA Netw Open 2021;4:e2111788.

   OpenUrl
2. 2.↵
   1. Ackermann M,
   2. Verleden SE,
   3. Kuehnel M,
   4. et al

   . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020;383:120–8.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Nopp S,
   2. Moik F,
   3. Jilma B,
   4. Pabinger I,
   5. Ay C

   . Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res Pract Thromb Haemost 2020;4:1178–91.

   OpenUrl
4. 4.↵
   1. Sadeghipour P,
   2. Talasaz AH,
   3. Rashidi F,
   4. et al

   . Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA 2021;325:1620–30.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Lopes RD,
   2. de Barros E Silva PGM

   , et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet 2021;397:2253–63.

   OpenUrlPubMed
6. 6.↵
   1. Roubinian NH,
   2. Dusendang JR,
   3. Mark DG,
   4. et al

   . Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California. JAMA Intern Med 2021;181:997–9.

   OpenUrl
7. 7.↵
   1. Connors JM,
   2. Brooks MM,
   3. Sciurba FC,
   4. et al

   . Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial. JAMA 2021;326:1703.

   OpenUrl
8. 8.↵
   1. Mackey K,
   2. Ayers CK,
   3. Kondo KK,
   4. et al

   . Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths: A Systematic Review. Ann Intern Med 2021;174:362–73.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Yu W,
   2. Rohli KE,
   3. Yang S,
   4. Jia P

   . Impact of obesity on COVID-19 patients. J Diabetes Complications 2021;35:107817.

   OpenUrl